(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 1890.40 | 934.60 | 102.27 | 1890.40 | 934.60 | 102.27 | 5970.30 | 4774.10 | 25.06 |
| Other Income | 95.60 | 130.20 | -26.57 | 95.60 | 130.20 | -26.57 | 381.40 | 696.70 | -45.26 |
| PBIDT | 655.70 | 328.60 | 99.54 | 655.70 | 328.60 | 99.54 | 1938.60 | 2058.00 | -5.80 |
| Interest | 25.30 | 22.30 | 13.45 | 25.30 | 22.30 | 13.45 | 100.40 | 58.70 | 71.04 |
| PBDT | 665.50 | 254.50 | 161.49 | 665.50 | 254.50 | 161.49 | 2032.40 | 1541.90 | 31.81 |
| Depreciation | 154.90 | 130.60 | 18.61 | 154.90 | 130.60 | 18.61 | 551.10 | 488.60 | 12.79 |
| PBT | 510.60 | 123.90 | 312.11 | 510.60 | 123.90 | 312.11 | 1481.30 | 1053.30 | 40.63 |
| TAX | -138.60 | -63.20 | 119.30 | -138.60 | -63.20 | 119.30 | 151.60 | 374.40 | -59.51 |
| Deferred Tax | -276.40 | 44.20 | -725.34 | -276.40 | 44.20 | -725.34 | 76.60 | -96.40 | -179.46 |
| PAT | 649.20 | 187.10 | 246.98 | 649.20 | 187.10 | 246.98 | 1329.70 | 678.90 | 95.86 |
| Equity | 195.60 | 97.80 | 100.00 | 195.60 | 97.80 | 100.00 | 195.60 | 97.80 | 100.00 |
| PBIDTM(%) | 34.69 | 35.16 | -1.35 | 34.69 | 35.16 | -1.35 | 32.47 | 43.11 | -24.68 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1949.00 |
| Dr. Reddys Labs. | 1172.00 |
| Cipla | 1472.00 |
| Lupin | 2360.00 |
| Zydus Lifesciences | 1115.20 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: